Page last updated: 2024-10-22

ag-1296 and Bilateral Wilms Tumor

ag-1296 has been researched along with Bilateral Wilms Tumor in 1 studies

6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase

Research Excerpts

ExcerptRelevanceReference
"The authors studied the effect of genistein (broad-spectrum GFR-TK inhibitor), AG1478 (EGFR-specific GFR-TK inhibitor), and AG1295 (PDGFR-specific GFR-TK inhibitor) on proliferation and colonigenic growth of rhabdoid tumor of the kidney and Wilms' tumor cell lines: G-401 and SK-NEP-1, respectively."3.70Receptor tyrosine kinase inhibition suppresses growth of pediatric renal tumor cells in vitro. ( DeMattia, JA; Khoshyomn, S; Naraghi, S; Vane, DW, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naraghi, S1
Khoshyomn, S1
DeMattia, JA1
Vane, DW1

Other Studies

1 other study available for ag-1296 and Bilateral Wilms Tumor

ArticleYear
Receptor tyrosine kinase inhibition suppresses growth of pediatric renal tumor cells in vitro.
    Journal of pediatric surgery, 2000, Volume: 35, Issue:6

    Topics: Adult; Cell Division; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Female; Genistein; Humans

2000